PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Biocon Limited (BIOCON.NS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

INE376G01013

Sector

Healthcare

Highlights

Market Cap

₹403.46B

EPS (TTM)

₹6.70

PE Ratio

50.27

Total Revenue (TTM)

₹146.68B

Gross Profit (TTM)

₹74.10B

EBITDA (TTM)

₹31.25B

Year Range

₹244.21 - ₹404.70

Target Price

₹382.70

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of ₹10,000 in Biocon Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-5.13%
13.25%
BIOCON.NS (Biocon Limited)
Benchmark (^GSPC)

Returns By Period

Biocon Limited had a return of -7.81% year-to-date (YTD) and 19.94% in the last 12 months. Over the past 10 years, Biocon Limited had an annualized return of 17.11%, outperforming the S&P 500 benchmark which had an annualized return of 11.31%.


BIOCON.NS

YTD

-7.81%

1M

-16.13%

6M

-5.13%

1Y

19.94%

5Y*

1.55%

10Y*

17.11%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of BIOCON.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-0.77%-7.81%
20247.51%3.02%-4.47%13.02%3.58%13.69%3.20%-0.90%1.11%-12.94%15.52%0.05%46.55%
2023-10.23%-2.51%-9.95%12.70%5.44%8.28%-2.60%0.88%4.95%-19.31%8.49%4.76%-4.10%
20220.67%-4.97%-3.80%9.79%-9.32%-7.54%-0.39%0.88%-6.11%-7.25%4.82%-7.42%-28.08%
2021-20.11%4.95%4.79%-7.15%2.25%4.19%-4.48%-7.12%1.07%-3.20%2.65%1.18%-21.65%
20200.22%-2.53%-5.70%30.83%0.21%9.98%5.00%-8.17%19.02%-9.85%6.38%8.40%58.46%
20193.06%-4.14%-2.33%-2.22%-8.69%-7.53%-9.41%3.99%-5.37%10.38%14.45%4.28%-6.44%
201814.44%2.46%-5.74%12.41%-0.33%-6.89%-5.19%6.41%10.79%-4.68%-5.26%0.75%17.27%
20176.43%11.03%0.88%-2.53%-14.05%4.69%16.49%-12.40%-1.44%8.15%20.31%24.33%70.11%
2016-5.55%-4.06%4.05%21.11%22.57%3.29%11.87%10.56%1.83%-0.84%-0.95%3.61%85.29%
2015-2.54%1.84%11.11%-2.55%-0.29%2.17%-0.81%-2.96%0.18%2.32%1.48%12.23%23.01%
2014-5.73%5.09%-7.43%10.97%-7.15%21.38%-10.53%-1.29%7.36%-10.08%1.89%-6.76%-7.11%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIOCON.NS is 58, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BIOCON.NS is 5858
Overall Rank
The Sharpe Ratio Rank of BIOCON.NS is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOCON.NS is 5555
Sortino Ratio Rank
The Omega Ratio Rank of BIOCON.NS is 5151
Omega Ratio Rank
The Calmar Ratio Rank of BIOCON.NS is 6060
Calmar Ratio Rank
The Martin Ratio Rank of BIOCON.NS is 6565
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Biocon Limited (BIOCON.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BIOCON.NS, currently valued at 0.42, compared to the broader market-2.000.002.000.421.74
The chart of Sortino ratio for BIOCON.NS, currently valued at 0.89, compared to the broader market-4.00-2.000.002.004.006.000.892.35
The chart of Omega ratio for BIOCON.NS, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.32
The chart of Calmar ratio for BIOCON.NS, currently valued at 0.33, compared to the broader market0.002.004.006.000.332.61
The chart of Martin ratio for BIOCON.NS, currently valued at 1.97, compared to the broader market0.0010.0020.0030.001.9710.66
BIOCON.NS
^GSPC

The current Biocon Limited Sharpe ratio is 0.42. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Biocon Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.42
2.22
BIOCON.NS (Biocon Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Biocon Limited provided a 0.15% dividend yield over the last twelve months, with an annual payout of ₹0.50 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%₹0.00₹0.50₹1.00₹1.5020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend₹0.50₹0.50₹1.50₹0.50₹0.00₹0.00₹0.50₹0.50₹0.50₹0.83₹0.83₹0.83

Dividend yield

0.15%0.14%0.60%0.19%0.00%0.00%0.17%0.16%0.19%0.53%0.97%1.17%

Monthly Dividends

The table displays the monthly dividend distributions for Biocon Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025₹0.00₹0.00₹0.00
2024₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50
2023₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹1.50₹0.00₹0.00₹0.00₹0.00₹0.00₹1.50
2022₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50
2021₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
2020₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00
2019₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50
2018₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50
2017₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50₹0.00₹0.00₹0.00₹0.00₹0.00₹0.50
2016₹0.00₹0.00₹0.83₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.83
2015₹0.00₹0.00₹0.00₹0.83₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.83
2014₹0.83₹0.00₹0.00₹0.00₹0.00₹0.00₹0.83

Dividend Yield & Payout


Dividend Yield
200.0%400.0%600.0%0.2%
Biocon Limited has a dividend yield of 0.15%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%8.0%
Biocon Limited has a payout ratio of 8.02%, which is below the market average. This means Biocon Limited returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-29.74%
0
BIOCON.NS (Biocon Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Biocon Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biocon Limited was 93.15%, occurring on Nov 28, 2008. Recovery took 2129 trading sessions.

The current Biocon Limited drawdown is 29.74%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.15%Jul 29, 2005825Nov 28, 20082129Jul 14, 20172954
-58.85%Dec 24, 2020559Mar 24, 2023
-43.16%Apr 13, 2004271May 2, 200563Jul 28, 2005334
-38.86%Sep 28, 2018242Sep 26, 2019135Apr 17, 2020377
-21.3%Jul 20, 201722Aug 21, 201762Nov 20, 201784

Volatility

Volatility Chart

The current Biocon Limited volatility is 11.41%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
11.41%
3.08%
BIOCON.NS (Biocon Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Biocon Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Biocon Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab